No defined direct molecular target

The designation 'No defined direct molecular target' is a classification used in pharmacological databases like ChEMBL and DrugBank to describe therapeutic agents that do not interact with a specific protein, such as a receptor, enzyme, or ion channel, to produce their effect (ChEMBL Database, 2024). Instead, these agents typically function through non-specific physical or chemical mechanisms. For example, osmotic diuretics like mannitol work by increasing the osmolarity of glomerular filtrate, while antacids like magnesium hydroxide chemically neutralize gastric acid (StatPearls, 'Antacids', 2023). This category also encompasses agents like activated charcoal, which acts via physical adsorption of toxins in the gastrointestinal tract, and certain medical imaging contrast agents like barium sulfate (PubChem, 2024). In some instances, this label is applied to drugs with well-established clinical efficacy but whose precise molecular triggers remain unknown or poorly characterized in scientific literature. Because these substances lack a specific molecular site of action, traditional drug discovery metrics like binding affinity (Kd) or inhibitory concentration (IC50) are generally not applicable.

Other names

Unknown targetNon-specific mechanismUndefined targetNon-molecular targetUnassigned target

Pharmacological action is exerted through physical, chemical, or osmotic properties rather than through binding to a specific macromolecular target such as a receptor or enzyme.